| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44030859 | HTLV-1 | ENSG00000157219.5 | protein_coding | HTR5A | No | No | 3361 | A4D2N2 P47898 |
| TVIS44050603 | HTLV-1 | ENSG00000157219.5 | protein_coding | HTR5A | No | No | 3361 | A4D2N2 P47898 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HTR5A |
|---|---|
| DrugBank ID | DB00246 |
| Drug Name | Ziprasidone |
| Target ID | BE0004688 |
| UniProt ID | P47898 |
| Regulation Type | antagonist |
| PubMed IDs | 17848919; 14965244 |
| Citations | Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11.@@Nelson DL: 5-HT5 receptors. Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):53-8. doi: 10.2174/1568007043482606. |
| Groups | Approved |
| Direct Classification | N-arylpiperazines |
| SMILES | ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1 |
| Pathways | |
| PharmGKB | PA451974 |
| ChEMBL | CHEMBL708 |
